Zobrazeno 1 - 10
of 169
pro vyhledávání: '"Esperanza, Such"'
Autor:
José Vicente Gil, Alberto Miralles, Sandra de las Heras, Esperanza Such, Gayane Avetisyan, Álvaro Díaz-González, Marta Santiago, Carolina Fuentes, José María Fernández, Pilar Lloret, Irene Navarro, Pau Montesinos, Marta Llop, Eva Barragán
Publikováno v:
Frontiers in Molecular Biosciences, Vol 11 (2024)
Introduction: Acute lymphoblastic leukemia (ALL) is a prevalent childhood cancer with high cure rate, but poses a significant medical challenge in adults and relapsed patients. Philadelphia-like acute lymphoblastic leukemia (Ph-like ALL) is a high-ri
Externí odkaz:
https://doaj.org/article/3a32d9f59b0341d4840faa5e7c3ee8d0
Autor:
Juan Carlos Caballero, Julio Dávila, María López-Pavía, Esperanza Such, Teresa Bernal, Fernando Ramos, Marisa Calabuig, Jesús María Hernández Sánchez, Helena Pomares, Mercedes Sánchez Barba, María Abáigar, Bernardo González, Brayan Merchán, Reyes Sancho-Tello, Marta Callejas, Carolina Muñoz-Novas, Carlos Cerveró, Guillermo Sanz, Jesús María Hernández Rivas, María Díez Campelo;
Publikováno v:
Therapeutic Advances in Hematology, Vol 15 (2024)
Background: Erythropoiesis stimulating agents (ESAs) are the first-line therapy in patients with lower-risk myelodysplastic syndromes (LR-MDS). Some predictive factors for ESAs response have been identified. Type and number of somatic mutations have
Externí odkaz:
https://doaj.org/article/aae5bf162b0d4831a1ded6c9dd145238
Autor:
Mar Mallo, Heinz Tuechler, Leonor Arenillas, Sophie Raynaud, Thomas Cluzeau, Lee‐Yung Shih, Chiang Tung‐Liang, Christina Ganster, Katayoon Shirneshan, Detlef Haase, Martí Mascaró, Laura Palomo, José Cervera, Esperanza Such, Nicola Trim, Sally Jeffries, Emma Ridgway, Giovanni Marconi, Giovanni Martinelli, Francesc Solé
Publikováno v:
eJHaem, Vol 4, Iss 2, Pp 446-449 (2023)
Abstract Half of the myelodysplastic syndromes (MDS) have normal karyotype by conventional banding analysis. The percentage of true normal karyotype cases can be reduced by 20–30% with the complementary application of genomic microarrays. We here p
Externí odkaz:
https://doaj.org/article/af726074fdc249d3b552e847cdac07ac
Autor:
Josgrey del Valle Navas Acosta, Teresa Gonzalez, Inmaculada Serramito, Cristina Miguel, Sandra Santos, Angela Villaverde, Jordi Ribera, Isabel Granada, Mireia Morgades, Ricardo Sánchez, Esperanza Such, Susana Barrera, Juana Ciudad, Alberto Orfao, Josep Maria Ribera, Julio Dávila Valls, Natalia De Las Heras Rodriguez, José Luis Fuster, Alfonso García de Coca, Jorge Labrador, Jose Antonio Queizan, Mª Carmen Mendoza, Susana Riesco, Rocío Benito, Jesus Hernández Rivas
Publikováno v:
HemaSphere, Vol 7, p e662369c (2023)
Externí odkaz:
https://doaj.org/article/ebf1fe75945f411985d2650f80a75450
Autor:
Sofía María Toribio Castelló, Sandra Castaño, Angela Villaverde-Ramiro, Esperanza Such, Montserrat Arnan, Francesc Solé, Marina Díaz Beyá, María Díez-Campelo, Mónica del Rey, Teresa González, Jesus Hernández Rivas
Publikováno v:
HemaSphere, Vol 7, p e877555b (2023)
Externí odkaz:
https://doaj.org/article/641fb7d44c22400caf72c8e0302030fa
Autor:
Álvaro Díaz González, Gayane Avetisyan, Cristian Garcia-Ruiz, José Vicente Gil, Marta Santiago, Juan José Domínguez-García, Marta Llop, Eva Barragan, Maria Leonor Senent Peris, Javier DE LA Rubia, José Cervera, Esperanza Such
Publikováno v:
HemaSphere, Vol 7, p e8338249 (2023)
Externí odkaz:
https://doaj.org/article/3b8292ebcb154ed4a860dfb92a532b39
Autor:
José Vicente Gil, Esperanza Such, Claudia Sargas, Javier Simarro, Alberto Miralles, Gema Pérez, Inmaculada de Juan, Sarai Palanca, Gayane Avetisyan, Marta Santiago, Carolina Fuentes, José María Fernández, Ana Isabel Vicente, Samuel Romero, Marta Llop, Eva Barragán
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 5, p 4440 (2023)
The molecular landscape of acute lymphoblastic leukemia (ALL) is highly heterogeneous, and genetic lesions are clinically relevant for diagnosis, risk stratification, and treatment guidance. Next-generation sequencing (NGS) has become an essential to
Externí odkaz:
https://doaj.org/article/476dc8d186764a17a893d2f8236bf10e
Publikováno v:
Blood Advances, Vol 3, Iss 21, Pp 3454-3460 (2019)
This article has a companion Point by Thol and Platzbecker.
Externí odkaz:
https://doaj.org/article/cdff40e25b2849ad9bdeeb7b43d3e8c7
Autor:
Mireia Boluda-Navarro, Mariam Ibáñez, Alessandro Liquori, Clara Franco-Jarava, Mónica Martínez-Gallo, Héctor Rodríguez-Vega, Jaijo Teresa, Carmen Carreras, Esperanza Such, Ángel Zúñiga, Roger Colobran, José Vicente Cervera
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Chédiak-Higashi syndrome (CHS) is a rare autosomal recessive (AR) immune disorder that has usually been associated to missense, nonsense or indels mutations in the LYST gene. In this study, we describe for the first time the case of a CHS patient ca
Externí odkaz:
https://doaj.org/article/77a9f1cd4690426aaaf8d7b36474252a
Autor:
Mariam Ibáñez, Esperanza Such, Alessandro Liquori, Gayane Avestisyan, Rafael Andreu, Ana Vicente, María José Macián, Mari Carmen Melendez, Mireya Morote-Faubel, Pedro Asensi, María Pilar Lloret, Isidro Jarque, Isabel Picón, Alejandro Pacios, Eva Donato, Carmen Mas-Ochoa, Carmen Alonso, Carolina Cañigral, Amparo Sempere, Samuel Romero, Marta Santiago, Guillermo F. Sanz, Javier de la Rubia, Leonor Senent, Irene Luna
Publikováno v:
Diagnostics, Vol 12, Iss 4, p 953 (2022)
According to current guidelines, in chronic lymphocytic leukemia (CLL), only the TP53 molecular status must be evaluated prior to every treatment’s initiation. However, additional heterogeneous genetic events are known to confer a proliferative adv
Externí odkaz:
https://doaj.org/article/c1a36a4eb20143799aaa0bfe6a9b11c3